Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einar Svarstad

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Scientific Reports|December 2, 2021
Accuracy of single intravenous access iohexol GFR in children is hampered by marker contaminationThea Tislevoll Eide, Karl Ove Hufthammer, Atle Brun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 26, 2013
Mortality in patients with IgA nephropathyThomas Knoop, Bjørn Egil Vikse, Einar Svarstad, et al.
Human Pathology|July 30, 2021
Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case seriesFriedemann Leh, Ida Viken Stalund, Tormod Karlsen Bjånes, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Use of 3D DCE-MRI for the estimation of renal perfusion and glomerular filtration rate: an intrasubject comparison of FLASH and KWIC with a comprehensive framework for evaluationEli Eikefjord, Erling Andersen, Erlend Hodneland, et al.
Pediatric Nephrology (Berlin, Germany)|July 3, 2016
Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling timesCamilla Tøndel, Bjørn Bolann, Cathrin Lytomt Salvador, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2022
Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug UseIda V Stalund, Heidi Grønseth, Finn P Reinholt, et al.
Kidney International|December 17, 2010
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry diseaseBehzad Najafian, Einar Svarstad, Leif Bostad, et al.
Plos One|April 20, 2016
Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort StudyPaschal Ruggajo, Einar Svarstad, Sabine Leh, et al.
Journal of the American Society of Nephrology : JASN|January 1, 2013
Agalsidase benefits renal histology in young patients with Fabry diseaseCamilla Tøndel, Leif Bostad, Kristin Kampevold Larsen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2007
Long-term risk of cancer in membranous nephropathy patientsRune Bjørneklett, Bjørn Egil Vikse, Einar Svarstad, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|December 2, 2021
Accuracy of single intravenous access iohexol GFR in children is hampered by marker contaminationThea Tislevoll Eide, Karl Ove Hufthammer, Atle Brun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 26, 2013
Mortality in patients with IgA nephropathyThomas Knoop, Bjørn Egil Vikse, Einar Svarstad, et al.
Human Pathology|July 30, 2021
Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case seriesFriedemann Leh, Ida Viken Stalund, Tormod Karlsen Bjånes, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Use of 3D DCE-MRI for the estimation of renal perfusion and glomerular filtration rate: an intrasubject comparison of FLASH and KWIC with a comprehensive framework for evaluationEli Eikefjord, Erling Andersen, Erlend Hodneland, et al.
Pediatric Nephrology (Berlin, Germany)|July 3, 2016
Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling timesCamilla Tøndel, Bjørn Bolann, Cathrin Lytomt Salvador, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2022
Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug UseIda V Stalund, Heidi Grønseth, Finn P Reinholt, et al.
Kidney International|December 17, 2010
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry diseaseBehzad Najafian, Einar Svarstad, Leif Bostad, et al.
Plos One|April 20, 2016
Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort StudyPaschal Ruggajo, Einar Svarstad, Sabine Leh, et al.
Journal of the American Society of Nephrology : JASN|January 1, 2013
Agalsidase benefits renal histology in young patients with Fabry diseaseCamilla Tøndel, Leif Bostad, Kristin Kampevold Larsen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2007
Long-term risk of cancer in membranous nephropathy patientsRune Bjørneklett, Bjørn Egil Vikse, Einar Svarstad, et al.
Pageof 7